pA1c®HI Postbiotic Ingredient for Glucose Control

pA1c®HI is a next-generation, food-grade postbiotic ingredient developed by Genbioma for glucose and metabolic health. Derived from a patented Pediococcus acidilactici strain, it is designed for dietary supplements, functional foods and beverages, combining clinical validation with industrial practicality.

• Clinically validated: positive human data in prediabetes, type 2 diabetes and obesity, with improvements reported in HbA1c, fasting glucose and insulin resistance.

• Microbiome-driven mode of action: developed to help modulate the gut microbiome and support endogenous metabolic pathways linked to glucose control.

• Heat-resistant and shelf-stable: maintains performance under demanding industrial conditions, including pasteurization and UHT, with up to 3 years of shelf life and no cold chain required.

• Formulation-friendly: suitable for capsules, gummies, powders, functional beverages and other food applications, with strong versatility for innovation across categories.

• Cost-efficient potential: active at low doses, enabling more competitive formulations for brands and manufacturers.

• Partner-ready ingredient: available as a bulk ingredient for B2B collaborations, with scalable manufacturing and ongoing interest from nutraceutical, food and pharma-related partners.

Ideal for companies looking for a science-backed, stable and market-ready postbiotic solution for next-generation metabolic health products.